We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Allegro MicroSystems
ALGM
$7.86B
| $1.29M | ﹤0.01% |
+35,734
| New | +$1.16M |
|
2327
CALL
Procter & Gamble
PG
$340B
| $1.29M | ﹤0.01% |
+7,900
| New | +$1.17M |
|
2328
Strategic Education
STRA
$1.98B
| $1.29M | ﹤0.01% |
22,344
-13,844
| -38% | -$868K |
|
|
NXRT
2329
NexPoint Residential Trust
NXRT
$689M
| $1.29M | ﹤0.01% |
+15,403
| New | +$1.14M |
|
|
CCRD
2330
DELISTED
CoreCard
CCRD
| $1.29M | ﹤0.01% |
33,259
+25,582
| +333% | +$1.06M |
|
2331
Sylvamo
SLVM
$1.52B
| $1.29M | ﹤0.01% |
+46,245
| New | +$1.35M |
|
|
AEVAW
2332
CALL
DELISTED
Aeva Technologies Warrants
AEVAW
| $1.28M | ﹤0.01% |
170,000
| – | – |
|
|
ARIS
2333
DELISTED
Aris Water Solutions
ARIS
| $1.27M | ﹤0.01% |
+98,611
| New | +$1.31M |
|
2334
Lindblad Expeditions
LIND
$1.95B
| $1.27M | ﹤0.01% |
81,739
+70,062
| +600% | +$1.11M |
|
|
FTPAW
2335
CALL
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
| $1.27M | ﹤0.01% |
130,864
| – | – |
|
|
BELFB
2336
Bel Fuse Inc Class B
BELFB
$3.45B
| $1.27M | ﹤0.01% |
98,398
-35,089
| -26% | -$451K |
|
2337
Bionano Genomics
BNGO
$12.5M
| $1.27M | ﹤0.01% |
+709
| New | +$1.9M |
|
|
PFTAW
2338
CALL
DELISTED
Perception Capital Corp. III Warrant
PFTAW
| $1.26M | ﹤0.01% |
+130,298
| New | +$104K |
|
2339
Zimmer Biomet
ZBH
$18.8B
| $1.26M | ﹤0.01% |
10,245
-57,491
| -85% | -$7.52M |
|
|
CCC
2340
CCC Intelligent Solutions
CCC
$3.55B
| $1.26M | ﹤0.01% |
+110,951
| New | +$1.29M |
|
2341
Virtus Investment Partners
VRTS
$1.12B
| $1.26M | ﹤0.01% |
+4,228
| New | +$1.31M |
|
|
FRONW
2342
CALL
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
| $1.25M | ﹤0.01% |
127,645
| – | – |
|
2343
PUT
Adobe
ADBE
$105B
| $1.25M | ﹤0.01% |
2,200
+1,600
| +267% | +$1M |
|
2344
Saic
SAIC
$4.95B
| $1.25M | ﹤0.01% |
14,924
-5,502
| -27% | -$478K |
|
2345
Domo
DOMO
$171M
| $1.25M | ﹤0.01% |
25,100
+21,530
| +603% | +$1.58M |
|
|
TWOU
2346
DELISTED
2U Inc
TWOU
| $1.24M | ﹤0.01% |
2,057
+1,774
| +627% | +$1.41M |
|
2347
Evergy
EVRG
$19.4B
| $1.24M | ﹤0.01% |
+18,020
| New | +$1.17M |
|
2348
Greif
GEF
$4.95B
| $1.23M | ﹤0.01% |
+20,426
| New | +$1.32M |
|
2349
Eldorado Gold
EGO
$8.33B
| $1.23M | ﹤0.01% |
+131,782
| New | +$1.22M |
|
|
SPPI
2350
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.23M | ﹤0.01% |
+969,105
| New | +$1.73M |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.